Article info

PDF

Pulmonary involvement in Fabry disease: effect of plasma globotriaosylsphingosine and time to initiation of enzyme replacement therapy

Authors

  1. Correspondence to Dr Daniel Franzen; daniel.franzen{at}usz.ch
View Full Text

Citation

Franzen D, Haile SR, Kasper DC, et al
Pulmonary involvement in Fabry disease: effect of plasma globotriaosylsphingosine and time to initiation of enzyme replacement therapy

Publication history

  • Received January 10, 2018
  • Revised March 20, 2018
  • First published April 21, 2018.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.